Becton, Dickinson and Company
BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central linā¦ read more
Healthcare
Medical Instruments & Supplies
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$159.36
Price-0.17%
-$0.27
1Y
Price
Market Cap
$57.735b
Large
Price/Earnings 3y Avg5y Avg
26x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+23.0%
EBITDA Margin+7.3%
Net Profit Margin+10.5%
Free Cash Flow Margin+23.0%
EBITDA Margin+7.3%
Net Profit Margin+10.5%
Free Cash Flow MarginRevenue
$21.923b
+0.4%
1y CAGR+4.3%
3y CAGR+3.9%
5y CAGREarnings
$1.757b
+4.7%
1y CAGR+6.0%
3y CAGR+0.4%
5y CAGREPS
$6.13
+5.2%
1y CAGR+7.8%
3y CAGR+1.8%
5y CAGRBook Value
$25.282b
$54.841b
Assets$29.559b
Liabilities$19.539b
DebtDebt to Assets
35.6%
3.8x
Debt to EBITDAFree Cash Flow
$2.631b
-1.5%
1y CAGR+10.2%
3y CAGR+14.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company